11
↑0
↓11
—0
Evidence suggests Melatonin maydecreaseTumor growth.
10 studies (11 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
10 of 11
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| melatonin | Decreases - combat | tumor growth | HumanMolecular | — | Not specified | Melatonin as a multifunctional anti-cancer molecule: Implications in gastric cancer.cited 38× |
| melatonin | Decreases - has oncostatic and antitumoral properties | tumor growth | Human | — | Not specified | Potential use of melatonin in skin cancer treatment: A review of current biological evidence.cited 32× |
| melatonin | Decreases - acts as an anti-inflammatory and reactive oxygen species inducer agent which suppresses | tumor growth | Human | — | Not specified | Potential use of melatonin in skin cancer treatment: A review of current biological evidence.cited 32× |
| melatonin | Decreases - exerts oncostatic effects | tumor growth | Human | — | Not specified | The emergence of melatonin in oncology: Focus on colorectal cancer.cited 48× |
| melatonin | Decreases - has been sparingly investigated to counteract | tumor growth | HumanMolecular | osteosarcoma cell lines | Not specified | Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma.cited 35× |
| melatonin | Decreases - regulation of these mediators by melatonin mitigates | tumor growth | Molecular | — | Not specified | Therapeutic targets of cancer drugs: Modulation by melatonin.cited 23× |
| melatonin | Decreases - reduction | tumor growth | Molecular | — | Not specified | Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.cited 117× |
| melatonin | Decreases - interferes with | tumor growth | Molecular | — | Not specified. | Melatonin modulates tumor metabolism and mitigates metastasis.cited 10× |
| Melatonin | Decreases - inhibited | tumor growth | HumanAnimalMolecular | xenograft mouse models | — | Quantum mechanics insights into melatonin and analogs binding to melatonin MT |
| Melatonin | Decreases - inhibited | tumor growth | AnimalMolecular | ascitic HCC mouse models using H22 cells | Not specified | Melatonin suppresses PD-L1 expression and exerts antitumor activity in hepatocellular carcinoma. |